Ranitidine Market – Global Industry Insights to 2026

Ranitidine Market – Size, Share, Outlook, and Opportunity Analysis 2018 - 2026
Spread the Word
Listed Under

* Ranitidine Market

* Health

* Seattle - Washington - US

* Reports

SEATTLE - July 22, 2019 - PRLog -- Healthcare professionals have been keenly interested in the treatment of gastroesophageal reflux disease (GERD) and stomach & intestinal ulcer owing to its increasing prevalence. GERD is common health problem, which leads to serious medical complications and further huge medical expense in its diagnosis and treatment. The two most frequently observed symptoms associated with GERD are heartburn and acid regurgitation. Usually, over-the-counter antacids, proton pump inhibitor, and H-2 receptor blockers are used to decrease the effects of stomach acids or to block acid production.

Ranitidine is a histamine H2 antagonists and available as both over-the-counter (OTC) and prescription drug, indicated in the treatment of gastroesophageal reflux disease (GERD). Ranitidine decreases the acid production from stomach for up to 12 hours. Also, ranitidine is commonly used in erosive esophagitis, peptide ulcer disease, and Zollinger–Ellison syndrome. It could be taken orally or intravenously.

To Access the Free Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2131

The global ranitidine market size was valued at US$ 412.4 Mn in 2017, and is expected to witness a CAGR of 1.8% over the forecast period (2018 – 2026).

Growing Research and Development (R&D) on Ranitidine is expected to Boost Market Growth

Various government and private research organizations are increasingly engaged in research and development studies to increase the efficacy of ranitidine and examine possible potential of ranitidine to increase future scope of ranitidine market.

Furthermore, various clinical trials are currently undergoing to identify and compare efficacy between ranitidine and other proton pump inhibitors such as esomeprazole and rabeprazole to measure gastric acid reduction in stomach. With the result of these studies, the efficacy of ranitidine is expected to improve and offer better treatment regimes in reducing excessive gastric acid production in the near future.

Get Full Access of This Business Report: https://www.coherentmarketinsights.com/market-insight/ranitidine-market-2131

Key players operating in the global ranitidine market include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Strides Pharma Science Limited (StridesShasun), Tocris Bioscience (R & D Systems), Merck KGaA, and Sun Pharmaceutical Industries Limited among others.

Detailed Segmentation:

Global Ranitidine Market, By Strength:

• 75 mg
• 150 mg
• 300 mg

Global Ranitidine Market, By Form:

• Tablet
• Syrup
• Injection

Global Ranitidine Market, By Route of Administration:

• Oral
• Intravenous
• Global Ranitidine Market, By Application:
• Intestinal & Stomach Ulcers
• Gastroesophageal Reflux Disease (GERD)
• Esophagitis
• Zollinger-Ellison Syndrome
• Other Application

To Get Instant Access, Purchase Report Here: https://www.coherentmarketinsights.com/insight/buy-now/2131

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Posted By:***@coherentmarketinsights.com Email Verified
Tags:Ranitidine Market
Location:Seattle - Washington - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Coherent Market Insights News
Most Viewed
Daily News

Like PRLog?
Click to Share